1. Acknowledgement

   Acknowledgments 28 November 2012 Pages: 991 - 993

2. When NICE Says No!

   • Alan Haycox

   Editorial 28 November 2012 Pages: 995 - 996

3. NICE Cost-Effectiveness Appraisal of Cholinesterase Inhibitors

   • Denis Getsios
   • Kristen Migliaccio-Walle
   • Jaime J. Caro

   Current Opinion 28 November 2012 Pages: 997 - 1006

   

4. Recombinant Factor VIIa (Eptacog Alfa)

   • Katherine A. Lyseng-Williamson
   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 28 November 2012 Pages: 1007 - 1029

   

5. Atorvastatin

   • Greg L. Plosker
   • Katherine A. Lyseng-Williamson

   Adis Pharmacoeconomic Drug Evaluation 28 November 2012 Pages: 1031 - 1053

   

6. Economic Evidence at the Local Level

   • Kees van Gool
   • Gisselle Gallego
   • Robyn Ward

   Leading Article 28 November 2012 Pages: 1055 - 1062

   

7. Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events

   • Bart Heeg
   • Joep Damen
   • Ben Van Hout

   Original Research Article 28 November 2012 Pages: 1063 - 1082